Breaking News Headlines Today | Ground News

See every side of every news story

Eyewire+ image

News from Eyewire+

Eyewire+’s media bias is unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

Eyewire+’s aggregated factuality score is Unknown. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about Eyewire+

Where is Eyewire+ located?Eyewire+'s Website

Media Bias Ratings

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Eyewire+ News

Regeneron Wins FDA Nod For Eylea HD With Reduced Injection Schedule For Patients With Vision Loss - Regeneron Pharmaceuticals (NASDAQ:REGN)

Pharma · United States

Regeneron Wins FDA Nod For Eylea HD With Reduced Injection Schedule For Patients With Vision Loss - Regeneron Pharmaceuticals (NASDAQ:REGN)

100% Center coverage: 2 sources

On Wednesday, the U.S. Food and Drug Administration (FDA) approved Regeneron Pharmaceuticals Inc.’s (NASDAQ:REGN) Eylea HD (aflibercept) Injection 8 mg for patients with macular edema following retinal vein occlusion (RVO) with up to every 8-week dosing after an initial monthly dosing period. RVO is a blockage in one of the veins that drain blood from the retina, causing blood and fluid to leak and potentially leading to vision loss. The FDA als…See the Story

AGC Biologics to Manufacture AAVantgarde’s Dual-Vector Gene Therapies for Inherited Retinal Disorders

Milan, Lombardy · Milan

AGC Biologics to Manufacture AAVantgarde’s Dual-Vector Gene Therapies for Inherited Retinal Disorders

100% Center coverage: 2 sources

MILAN--(BUSINESS WIRE)--Nov 21, 2025-See the Story

Israeli woman's vision restored in world's first-ever 3D-printed cornea implant

Israeli woman's vision restored in world's first-ever 3D-printed cornea implant

100% Center coverage: 1 sources

The new Israeli technology allows for the creation of hundreds of cornea implants from a single donor sample, offering a scalable solution.See the Story

Breaking News Topics Related to Eyewire+